Who has invested in Mirai Bio?

Flagship Pioneering are named among the investors backing Mirai Bio.

Mirai Bio Funding: $120M Raised, Series A (2024)

Mirai Bio funding overview

Mirai Bio is a Biotech company. Mirai Bio has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Mirai Bio runs through 2024; nothing later has been disclosed. Investors on record include Flagship Pioneering.

Mirai Bio at a glance

Total raised: $120M
Latest round: Series A
Latest round date: September 2024
Industry: Biotech
Notable investors: Flagship Pioneering

Frequently asked about Mirai Bio funding

How much has Mirai Bio raised?: Mirai Bio has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Mirai Bio?: Flagship Pioneering are named among the investors backing Mirai Bio.
What was the latest Mirai Bio funding round?: The most recent disclosed round is a Series A, announced in September 2024.
Where is Mirai Bio based?: No headquarters location is disclosed for Mirai Bio.
What sector does Mirai Bio operate in?: Mirai Bio is tracked under Biotech, with $120M in disclosed funding.
When did Mirai Bio last raise?: The last disclosed Mirai Bio round closed in September 2024 at Series A.

We update the Mirai Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.

Mirai Bio Funding: $120M Raised, Series A (2024)

Mirai Bio funding overview

Mirai Bio at a glance

Frequently asked about Mirai Bio funding

Companies related to Mirai Bio (36)

Browse related funding lists (4)